How to appeal a CareFirst BCBS substance use disorder treatment (sud/moud) denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

CareFirst BCBS-specific note: BCBS licensee for Maryland, DC, and northern Virginia (~3.5M members). Operates as non-profit. Appeals jurisdiction depends on policy issue location — MIA (MD), DISB (DC), or SCC Bureau of Insurance (VA). CVS Caremark is the PBM.

What CareFirst BCBS's policy requires for substance use disorder treatment (sud/moud)

Cited policy: Anthem clinical guideline (SUD Treatment) + BCBS plan-specific MAT policies

ASAM-referenced. ACA EHB compliance for SUD. BlueCard residential criteria.

How CareFirst BCBS denies substance use disorder treatment (sud/moud) — and how to counter it

Where CareFirst BCBS pushes back: 1) Residential 3.5/3.7 denied — 'lower LOC adequate'; 2) LOS denial at concurrent review (typically 14 days); 3) Methadone OTP coverage gaps in commercial plans.

Counter-arguments that hold up: CG-BEH-04 explicitly references ASAM Criteria — cite payer's own policy + ASAM 4e dimensions. ACA EHB §1302(b)(1)(E) — SUD is essential benefit; commercial methadone exclusion likely violates EHB and parity. Wit v. UBH (9th Cir. 2023) re LOC criteria deviating from generally accepted standards — precedent applies to non-GASC criteria.

What CareFirst BCBS typically denies for substance use disorder treatment (sud/moud)

Across CareFirst BCBS's commercial and Medicare books, denials cluster around a small number of patterns. For substance use disorder treatment (sud/moud), expect:

• DC/MD/VA cross-jurisdiction issues
• Step therapy on specialty drugs via CVS Caremark
• Behavioral health network adequacy
• BlueChoice HMO referral denials

Treatments most often denied in this category

These are the substance use disorder treatment (sud/moud) treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Suboxone (subli)
• Sublocade LA
• Brixadi LA
• Methadone OTP
• Vivitrol LA
• Naltrexone PO

How to submit the appeal to CareFirst BCBS

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document CareFirst BCBS cited in the denial.
3. File the appeal through CareFirst BCBS's portal (members: https://member.carefirst.com ; providers: https://provider.carefirst.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MD, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See CareFirst BCBS's prior-authorization criteria by drug: CareFirst BCBS PA criteria on ApprovalHelp.